NAV Growth

Growth of each fund's NAV over the selected period, rebased to 0%

Growth of each fund's NAV over the selected period, rebased to 0%

‌

Fund Details

Fund Details	ITI Pharma and Healthcare Fund - Dir (G)	Quant Healthcare Fund - Direct (G)
Fund Type	Equity	Equity
Risk	Very High	Very High
Min SIP Amount	₹500	₹1,000
Min Lumpsum	₹5,000	₹5,000
Expense Ratio	0.89%	1.62%
NAV	₹20.64 (11 Nov 2026)	₹19.50 (11 Nov 2026)
Fund Size	₹266.72 Cr	₹416.60 Cr
Fund Started	08 Nov 2021	17 Jul 2023
Lock-in Period	No lock-in	No lock-in
Exit Load	If redeemed/Switched out on or before 3 Months from the date of allotment Exit Load is 0.50% Exit Load after completion of 3 months - NIL.	1%For redemptions / switch outs (including SIP/STP) within 15 days from the date of allotment of units, irrepective of the amount of investment

Returns	ITI Pharma and Healthcare Fund - Dir (G)	Quant Healthcare Fund - Direct (G)
1M	8.44%	6.70%
3M	3.35%	5.15%
6M	13.49%	15.68%
1Y	17.13%	24.43%
3Y	20.85%	21.92%
5Y	15.59%	—
Since Inception	15.59%	22.51%

Trailing risk-adjusted performance measures

Risk Ratio	ITI Pharma and Healthcare Fund - Dir (G)	Quant Healthcare Fund - Direct (G)
Alpha	-0.46	1.65
Beta	0.96	0.89
Sharpe	0.86	0.84
Standard Deviation	4.76	5.25

Holding Analysis	ITI Pharma and Healthcare Fund - Dir (G)	Quant Healthcare Fund - Direct (G)
Top 5 Holdings	36.48%	60.48%
Top 10 Holdings	56.97%	100.20%
Portfolio Turnover	0.47	5.19
Equity	99.31%	66.44%
Debt	—	27.54%
Cash	—	—

Name	Assets
Sun Pharmaceutical ...Equity	11.96%
Divis Laboratories LtdEquity	9.51%
Apollo Hospitals En...Equity	5.45%
Torrent Pharmaceuti...Equity	4.78%
Dr Reddys Laborator...Equity	4.78%
Max Healthcare Inst...Equity	4.49%
Cipla LtdEquity	4.19%
Laurus Labs LtdEquity	4.02%
Aurobindo Pharma LtdEquity	4.01%
Mankind Pharma LtdEquity	3.78%

Name	Assets

Fund Manager	ITI Pharma and Healthcare Fund - Dir (G)	Quant Healthcare Fund - Direct (G)
Name	,

About	ITI Pharma and Healthcare Fund - Dir (G)	Quant Healthcare Fund - Direct (G)
AMC	ITI Mutual Fund	Quant Mutual Fund
Scheme Category	Sectoral Fund	Sectoral Fund
Benchmark	NIFTY Healthcare TRI	NIFTY Healthcare TRI
Launch Date	18 Oct 2021	27 Jun 2023

TREPSReverse Repo	21.10%
Zydus Lifesciences LtdEquity	10.25%
Divis Laboratories LtdDerivatives - Stock Future	9.92%
Aurobindo Pharma LtdEquity	9.83%
Glenmark Pharmaceut...Derivatives - Stock Future	9.38%
Glaxosmithkline Pha...Equity	8.89%
Strides Pharma Scie...Equity	8.79%
Torrent Pharmaceuti...Derivatives - Stock Future	8.46%
Pfizer LtdEquity	7.14%
TBILL-91DT Bills	6.44%